Literature DB >> 27053186

A Review of Laser Treatment for Symptomatic BPH (Benign Prostatic Hyperplasia).

Shiva Madhwan Nair1, Marie Adrianne Pimentel1, Peter John Gilling2.   

Abstract

Benign prostatic hyperplasia (BPH) is the predominant cause of bladder outflow obstruction and is associated with significant morbidity. Surgical removal of adenoma has been a key treatment principle for alleviation of obstruction. Lasers have been used as an alternative to transurethral resection of the prostate (TURP), due to the higher complications of the latter procedure, since the early 1990s. Early generations of lasers utilized coagulative and ablative techniques to dis-obstruct the bladder. Ablative techniques have remained popular with the resurgence of 532-nm vaporization (commonly known as GreenLight). Enucleation techniques especially with the holmium laser have shown durable efficacy in randomized controlled trials whilst new modalities such as thulium still require long-term data. This review examines the most common types of laser technology used in BPH surgery, with a focus on efficacy and side effect profile.

Entities:  

Keywords:  Ablation; Benign prostatic hyperplasia; Complications; Efficacy; Enucleation; Laser

Mesh:

Year:  2016        PMID: 27053186     DOI: 10.1007/s11934-016-0603-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  62 in total

1.  Holmium laser enucleation of the prostate technique for benign prostatic hyperplasia.

Authors:  Douglas C Kelly; Akhil Das
Journal:  Can J Urol       Date:  2012-02       Impact factor: 1.344

2.  Stress incontinence during the learning curve of holmium laser enucleation of the prostate.

Authors:  Lori B Lerner; Mark D Tyson; Pierre J Mendoza
Journal:  J Endourol       Date:  2010-10       Impact factor: 2.942

3.  Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years.

Authors:  Peter J Gilling; Liam C Wilson; Colleen J King; Andre M Westenberg; Christopher M Frampton; Mark R Fraundorfer
Journal:  BJU Int       Date:  2011-08-23       Impact factor: 5.588

Review 4.  Thulium: YAG 2 mum cw laser prostatectomy: where do we stand?

Authors:  T Bach; S J Xia; Y Yang; S Mattioli; G M Watson; A J Gross; T R W Herrmann
Journal:  World J Urol       Date:  2010-03-05       Impact factor: 4.226

5.  Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.

Authors:  Steffen Rausch; Thomas Heider; Jens Bedke; Stephan Kruck; Christian Schwentner; Karsten Fischer; Arnulf Stenzl; Tilman Kälble
Journal:  Urology       Date:  2015-01       Impact factor: 2.649

6.  Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate.

Authors:  Min Chul Cho; Ji Hyun Park; Min Su Jeong; Jun-Seok Yi; Ja Hyeon Ku; Seung-June Oh; Soo Woong Kim; Jae-Seung Paick
Journal:  Neurourol Urodyn       Date:  2011-04-28       Impact factor: 2.696

7.  High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later.

Authors:  R S Malek; D M Barrett; R S Kuntzman
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

Review 8.  Holmium laser applications of the prostate.

Authors:  Lori B Lerner; Mark D Tyson
Journal:  Urol Clin North Am       Date:  2009-11       Impact factor: 2.241

9.  A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  J Urol       Date:  2014-09-16       Impact factor: 7.450

10.  A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: urodynamic effects.

Authors:  Harm H Van Melick; Ger E P M Van Venrooij; Mardy D Eckhardt; Tom A Boon
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

View more
  14 in total

1.  Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies.

Authors:  Chaohui Gu; Naichun Zhou; Pratik Gurung; Yiping Kou; Yang Luo; Yidi Wang; Hui Zhou; Cheng Zhen; Jinjian Yang; Fengyan Tian; Guan Wu
Journal:  World J Urol       Date:  2019-06-17       Impact factor: 4.226

2.  Detection of blackbody radiation during fiber guided laser-tissue vaporization.

Authors:  Paris Franz; Xiaomei Wang; Hui Zhu; Ray Chia; Tom Hasenberg; Hui Wang
Journal:  Biomed Opt Express       Date:  2020-01-14       Impact factor: 3.732

3.  Transurethral vaporesection of prostate: diode laser or thulium laser?

Authors:  Xinji Tan; Xiaobo Zhang; Dongjie Li; Xiong Chen; Yuanqing Dai; Jie Gu; Mingquan Chen; Sheng Hu; Yao Bai; Yu Ning
Journal:  Lasers Med Sci       Date:  2018-04-10       Impact factor: 3.161

4.  Temperature assessment study of ex vivo holmium laser enucleation of the prostate model.

Authors:  Mehmet Yilmaz; Cäcilia Elisabeth Maria Heuring; Franz Friedrich Dressler; Rodrigo Suarez-Ibarrola; Christian Gratzke; Arkadiusz Miernik; Simon Hein
Journal:  World J Urol       Date:  2022-05-25       Impact factor: 3.661

Review 5.  Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Jiye Kim; Roderick MacDonald; Balaji Reddy; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

6.  Impact of diabetes mellitus on urinary continence after holmium laser enucleation of the prostate due to lower urinary tract symptoms: a retrospective study.

Authors:  Onur Acikgoz; Mehmet Yilmaz; Halil Cagri Aybal; Sercan Yilmaz; Eymen Gazel; Serdar Yalcin; Mehmet Duvarci; Engin Kaya; Arkadiusz Miernik; Lutfi Tunc
Journal:  Cent European J Urol       Date:  2021-10-22

Review 7.  Safety and Efficacy of Laser Enucleation of the Prostate in Elderly Patients - A Narrative Review.

Authors:  Mehmet Yilmaz; Julia Esser; Rodrigo Suarez-Ibarrola; Christian Gratzke; Arkadiusz Miernik
Journal:  Clin Interv Aging       Date:  2022-01-08       Impact factor: 4.458

8.  Risk Factors of Emergency Room Visits for Bleeding Complications Following Transurethral Procedures in the Treatment of Benign Prostatic Hyperplasia: A Retrospective Cohort Study.

Authors:  Tzu-Chi Teng; I-Hung Shao; Yu-Chao Hsu; Yu Chen; Shu-Han Tsao; Yen-Te Kang; Ming-Li Hsieh
Journal:  Clin Interv Aging       Date:  2021-09-29       Impact factor: 4.458

9.  5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia.

Authors:  Juhyun Park; Sung Yong Cho; Min Chul Cho; Hyeon Jeong; Hwancheol Son
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

10.  Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.

Authors:  Changlei Yao; Hongfa Li; Weitao Zhang
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Mar-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.